Sign In

Login

Password

Forgot Password ? Sign Up

Christoph Kleinschnitz (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Christoph Kleinschnitz" in German language version.

refsWebsite
Global rank German rank
60redirecter.toolforge.org
33rd place
2nd place
56web.archive.org
1st place
1st place
20doi.org
2nd place
3rd place
19nih.gov
4th place
7th place
18zdb-katalog.de
123rd place
6th place
4archive.today
14th place
31st place
3d-nb.info
511th place
112th place
2dnb.de
2,297th place
183rd place
1dfg.de
low place
1,597th place
1jrheum.org
low place
low place
1thelancet.com
2,393rd place
2,660th place
1clinicaltrials.gov
5,225th place
2,461st place
1rtl.de
1,285th place
77th place
1amsel.de
low place
low place

amsel.de

archive.today

clinicaltrials.gov

d-nb.info

  • Kleinschnitz, Christoph. In: Katalog der Deutschen Nationalbibliothek. Deutsche Nationalbibliothek, Frankfurt am Main, abgerufen am 21. August 2024.
  • Christoph Kleinschnitz: Verteilung und subzelluläre Lokalisation des Stickstoffmonoxid-Rezeptorenzyms, lösliche Guanylylcyclase. Julius-Maximilians-Universität Würzburg, Würzburg 2001, DNB 963101382 (93 Bl., d-nb.info [abgerufen am 20. August 2024] Hochschulschrift Dissertation).
  • Christoph Kleinschnitz: In-vivo-Darstellung und therapeutische Beeinflussung der Infarktexpansion nach zerebraler Ischämie: Mechanismen der Thrombenbildung und Neuroprotektion. Julius-Maximilians-Universität Würzburg, Würzburg 2007, DNB 991210182, S. 64 (d-nb.info [abgerufen am 20. August 2024] Hochschulschrift Habilitationsschrift).

dfg.de

dnb.de

portal.dnb.de

  • Christoph Kleinschnitz: Verteilung und subzelluläre Lokalisation des Stickstoffmonoxid-Rezeptorenzyms, lösliche Guanylylcyclase. Julius-Maximilians-Universität Würzburg, Würzburg 2001, DNB 963101382 (93 Bl., d-nb.info [abgerufen am 20. August 2024] Hochschulschrift Dissertation).
  • Christoph Kleinschnitz: In-vivo-Darstellung und therapeutische Beeinflussung der Infarktexpansion nach zerebraler Ischämie: Mechanismen der Thrombenbildung und Neuroprotektion. Julius-Maximilians-Universität Würzburg, Würzburg 2007, DNB 991210182, S. 64 (d-nb.info [abgerufen am 20. August 2024] Hochschulschrift Habilitationsschrift).

doi.org

  • Thomas Hünig: The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account. In: FEBS – Federation of European Biochemical Societies (Hrsg.): The FEBS Journal. Band 283, Nr. 18. Wiley, 18. Mai 2016, S. 3325–3334, doi:10.1111/febs.13754, PMID 27191544.
  • Jean-François Tanguay, Pascale Geoffroy, Martin G. Sirois, Danielle Libersan, Anjali Kumar, Robert G. Schaub, Yahye Merhi: Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. In: Thrombosis and Haemostasis. Band 91, Nr. 6, Juni 2004, S. 1186–1193, doi:10.1160/TH03-11-0701, PMID 15175806.
  • Bernhard Nieswandt, Christoph Kleinschnitz, Guido Stoll: Ischaemic stroke: a thrombo-inflammatory disease? In: The Journal of Physiology. Band 589, Nr. 17, 1. September 2011, ISSN 1469-7793, S. 4115–4123, doi:10.1113/jphysiol.2011.212886, PMID 21768262, PMC 3180572 (freier Volltext).
  • Simon F. De Meyer, Friederike Langhauser, Steffen Haupeltshofer, Christoph Kleinschnitz, Ana I. Casas: Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives. In: Stroke. Band 53, Nr. 5, Mai 2022, ISSN 1524-4628, S. 1487–1499, doi:10.1161/STROKEAHA.122.038733, PMID 35360931.
  • Ina Hagedorn, Stefan Schmidbauer, u. a.: Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. In: Circulation. Band 121, Nr. 13, 6. April 2010, ISSN 1524-4539, S. 1510–1517, doi:10.1161/CIRCULATIONAHA.109.924761, PMID 20308613.
  • Christoph Kleinschnitz, Guido Stoll, u. a.: Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. In: The Journal of Experimental Medicine. Band 203, Nr. 3, 20. März 2006, ISSN 0022-1007, S. 513–518, doi:10.1084/jem.20052458, PMID 16533887, PMC 2118228 (freier Volltext).
  • Thomas Renné, Miroslava Pozgajová, u. a.: Defective thrombus formation in mice lacking coagulation factor XII. In: The Journal of Experimental Medicine. Band 202, Nr. 2, 18. Juli 2005, ISSN 0022-1007, S. 271–281, doi:10.1084/jem.20050664, PMID 16009717, PMC 2213000 (freier Volltext).
  • Christoph Kleinschnitz, Nicholas Schwab, Peter Kraft, Ina Hagedorn, Angela Dreykluft, Tobias Schwarz, Madeleine Austinat, Bernhard Nieswandt, Heinz Wiendl, Guido Stoll: Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. In: Blood. Band 115, Nr. 18, 6. Mai 2010, ISSN 1528-0020, S. 3835–3842, doi:10.1182/blood-2009-10-249078, PMID 20215643.
  • Christoph Kleinschnitz, Peter Kraft, u. a.: Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. In: Blood. Band 121, Nr. 4, 24. Januar 2013, ISSN 1528-0020, S. 679–691, doi:10.1182/blood-2012-04-426734, PMID 23160472, PMC 3790947 (freier Volltext).
  • Michael K. Schuhmann, Peter Kraft, u. a.: CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke. In: Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. Band 35, Nr. 1, Januar 2015, ISSN 1559-7016, S. 6–10, doi:10.1038/jcbfm.2014.175, PMID 25315859, PMC 4294400 (freier Volltext).
  • Jonathan P. Piccini, Valeria Caso, u. a.: Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. In: The Lancet. Band 399, Nr. 10333, 9. April 2022, ISSN 0140-6736, S. 1383–1390, doi:10.1016/S0140-6736(22)00456-1, PMID 35385695 (thelancet.com [abgerufen am 6. April 2023]).
  • Michael Fleischer, Martin Köhrmann, Sebastian Dolff, Fabian Szepanowski, Karsten Schmidt, Frank Herbstreit, Cansu Güngör, Benjamin Stolte, Katharina Marie Steiner, Christine Stadtler, Joachim Riße, Melanie Fiedler, Gerd Meyer Zu Hörste, Anne-K. Mausberg, Clemens Kill, Michael Forsting, Ulrich Sure, Ulf Dittmer, Oliver Witzke, Thorsten Brenner, Christoph Kleinschnitz, Mark Stettner: Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. In: Therapeutic Advances in Neurological Disorders. Band 14, 2021, ISSN 1756-2856, S. 1756286421993701, doi:10.1177/1756286421993701, PMID 33737955, PMC 7934032 (freier Volltext).
  • Michael Heming, Xiaolin Li, Saskia Räuber, Anne K. Mausberg, Anna-Lena Börsch, Maike Hartlehnert, Arpita Singhal, I.-Na Lu, Michael Fleischer, Fabian Szepanowski, Oliver Witzke, Thorsten Brenner, Ulf Dittmer, Nir Yosef, Christoph Kleinschnitz, Heinz Wiendl, Mark Stettner, Gerd Meyer Zu Hörste: Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. In: Immunity. Band 54, Nr. 1, 12. Januar 2021, ISSN 1097-4180, S. 164–175.e6, doi:10.1016/j.immuni.2020.12.011, PMID 33382973, PMC 7831653 (freier Volltext).
  • Michael Fleischer, Fabian Szepanowski, Muriel Tovar, Klaas Herchert, Hannah Dinse, Adam Schweda, Anne K. Mausberg, Dagny Holle-Lee, Martin Köhrmann, Julia Stögbauer, Daniel Jokisch, Martha Jokisch, Cornelius Deuschl, Eva-Maria Skoda, Martin Teufel, Mark Stettner, Christoph Kleinschnitz: Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. In: Neurology and Therapy. Band 11, Nr. 4, Dezember 2022, ISSN 2193-6536, S. 1637–1657, doi:10.1007/s40120-022-00395-z, PMID 36028604, PMC 9417089 (freier Volltext).
  • Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. In: Therapeutic Advances in Neurological Disorders. Band 17, Januar 2024, ISSN 1756-2864, doi:10.1177/17562864241229567, PMID 38348267, PMC 10860378 (freier Volltext).
  • Mark Vink, Tilman Grande, Matthias Kohl: Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic. In: Neurology and Therapy. Band 12, Nr. 1, Februar 2023, ISSN 2193-6536, S. 329–332, doi:10.1007/s40120-022-00426-9, PMID 36508159, PMC 9744047 (freier Volltext).
  • Matthias Kohl: Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. In: Therapeutic Advances in Neurological Disorders. Band 17, Januar 2024, ISSN 1756-2864, doi:10.1177/17562864241254268, PMID 38827241, PMC 11143864 (freier Volltext).
  • National Academies of Sciences, Engineering, and Medicine: Long-Term Health Effects of COVID-19: Disability and Function Following SARS-CoV-2 Infection. National Academies Press, Washington, D.C. 2024, ISBN 978-0-309-71860-8, S. 92, doi:10.17226/27756 (freier Volltext).
  • Ziyad Al-Aly, Hannah Davis, Lisa McCorkell, Letícia Soares, Sarah Wulf-Hanson, Akiko Iwasaki, Eric J. Topol: Long COVID science, research and policy. In: Nature Medicine. 9. August 2024, ISSN 1078-8956, S. 5, doi:10.1038/s41591-024-03173-6 (freier Volltext).
  • Todd E. Davenport, Svetlana Blitshteyn, Nicola Clague-Baker, David Davies-Payne, Glenn J. Treisman, Sarah F. Tyson: Long COVID Is Not a Functional Neurologic Disorder. In: Journal of Personalized Medicine. Band 14, Nr. 8, 29. Juli 2024, ISSN 2075-4426, doi:10.3390/jpm14080799 (freier Volltext).

jrheum.org

  • Marta Rodríguez-Palmero, Angels Franch, Margarida Castell, Carme Pelegrí, Francisco J. Pérez-Cano, Christoph Kleinschnitz, Guido Stoll, Thomas Hünig, Cristina Castellote: Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody. In: The Journal of Rheumatology. Band 33, Nr. 1, Januar 2006, ISSN 1499-2752, S. 110–118, PMID 16395758 (jrheum.org).

nih.gov

ncbi.nlm.nih.gov

  • Marta Rodríguez-Palmero, Angels Franch, Margarida Castell, Carme Pelegrí, Francisco J. Pérez-Cano, Christoph Kleinschnitz, Guido Stoll, Thomas Hünig, Cristina Castellote: Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody. In: The Journal of Rheumatology. Band 33, Nr. 1, Januar 2006, ISSN 1499-2752, S. 110–118, PMID 16395758 (jrheum.org).
  • Thomas Hünig: The rise and fall of the CD 28 superagonist TGN 1412 and its return as TAB 08: a personal account. In: FEBS – Federation of European Biochemical Societies (Hrsg.): The FEBS Journal. Band 283, Nr. 18. Wiley, 18. Mai 2016, S. 3325–3334, doi:10.1111/febs.13754, PMID 27191544.
  • Jean-François Tanguay, Pascale Geoffroy, Martin G. Sirois, Danielle Libersan, Anjali Kumar, Robert G. Schaub, Yahye Merhi: Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. In: Thrombosis and Haemostasis. Band 91, Nr. 6, Juni 2004, S. 1186–1193, doi:10.1160/TH03-11-0701, PMID 15175806.
  • Bernhard Nieswandt, Christoph Kleinschnitz, Guido Stoll: Ischaemic stroke: a thrombo-inflammatory disease? In: The Journal of Physiology. Band 589, Nr. 17, 1. September 2011, ISSN 1469-7793, S. 4115–4123, doi:10.1113/jphysiol.2011.212886, PMID 21768262, PMC 3180572 (freier Volltext).
  • Simon F. De Meyer, Friederike Langhauser, Steffen Haupeltshofer, Christoph Kleinschnitz, Ana I. Casas: Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives. In: Stroke. Band 53, Nr. 5, Mai 2022, ISSN 1524-4628, S. 1487–1499, doi:10.1161/STROKEAHA.122.038733, PMID 35360931.
  • Ina Hagedorn, Stefan Schmidbauer, u. a.: Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. In: Circulation. Band 121, Nr. 13, 6. April 2010, ISSN 1524-4539, S. 1510–1517, doi:10.1161/CIRCULATIONAHA.109.924761, PMID 20308613.
  • Christoph Kleinschnitz, Guido Stoll, u. a.: Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. In: The Journal of Experimental Medicine. Band 203, Nr. 3, 20. März 2006, ISSN 0022-1007, S. 513–518, doi:10.1084/jem.20052458, PMID 16533887, PMC 2118228 (freier Volltext).
  • Thomas Renné, Miroslava Pozgajová, u. a.: Defective thrombus formation in mice lacking coagulation factor XII. In: The Journal of Experimental Medicine. Band 202, Nr. 2, 18. Juli 2005, ISSN 0022-1007, S. 271–281, doi:10.1084/jem.20050664, PMID 16009717, PMC 2213000 (freier Volltext).
  • Christoph Kleinschnitz, Nicholas Schwab, Peter Kraft, Ina Hagedorn, Angela Dreykluft, Tobias Schwarz, Madeleine Austinat, Bernhard Nieswandt, Heinz Wiendl, Guido Stoll: Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. In: Blood. Band 115, Nr. 18, 6. Mai 2010, ISSN 1528-0020, S. 3835–3842, doi:10.1182/blood-2009-10-249078, PMID 20215643.
  • Christoph Kleinschnitz, Peter Kraft, u. a.: Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. In: Blood. Band 121, Nr. 4, 24. Januar 2013, ISSN 1528-0020, S. 679–691, doi:10.1182/blood-2012-04-426734, PMID 23160472, PMC 3790947 (freier Volltext).
  • Michael K. Schuhmann, Peter Kraft, u. a.: CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke. In: Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. Band 35, Nr. 1, Januar 2015, ISSN 1559-7016, S. 6–10, doi:10.1038/jcbfm.2014.175, PMID 25315859, PMC 4294400 (freier Volltext).
  • Jonathan P. Piccini, Valeria Caso, u. a.: Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. In: The Lancet. Band 399, Nr. 10333, 9. April 2022, ISSN 0140-6736, S. 1383–1390, doi:10.1016/S0140-6736(22)00456-1, PMID 35385695 (thelancet.com [abgerufen am 6. April 2023]).
  • Michael Fleischer, Martin Köhrmann, Sebastian Dolff, Fabian Szepanowski, Karsten Schmidt, Frank Herbstreit, Cansu Güngör, Benjamin Stolte, Katharina Marie Steiner, Christine Stadtler, Joachim Riße, Melanie Fiedler, Gerd Meyer Zu Hörste, Anne-K. Mausberg, Clemens Kill, Michael Forsting, Ulrich Sure, Ulf Dittmer, Oliver Witzke, Thorsten Brenner, Christoph Kleinschnitz, Mark Stettner: Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. In: Therapeutic Advances in Neurological Disorders. Band 14, 2021, ISSN 1756-2856, S. 1756286421993701, doi:10.1177/1756286421993701, PMID 33737955, PMC 7934032 (freier Volltext).
  • Michael Heming, Xiaolin Li, Saskia Räuber, Anne K. Mausberg, Anna-Lena Börsch, Maike Hartlehnert, Arpita Singhal, I.-Na Lu, Michael Fleischer, Fabian Szepanowski, Oliver Witzke, Thorsten Brenner, Ulf Dittmer, Nir Yosef, Christoph Kleinschnitz, Heinz Wiendl, Mark Stettner, Gerd Meyer Zu Hörste: Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. In: Immunity. Band 54, Nr. 1, 12. Januar 2021, ISSN 1097-4180, S. 164–175.e6, doi:10.1016/j.immuni.2020.12.011, PMID 33382973, PMC 7831653 (freier Volltext).
  • Michael Fleischer, Fabian Szepanowski, Muriel Tovar, Klaas Herchert, Hannah Dinse, Adam Schweda, Anne K. Mausberg, Dagny Holle-Lee, Martin Köhrmann, Julia Stögbauer, Daniel Jokisch, Martha Jokisch, Cornelius Deuschl, Eva-Maria Skoda, Martin Teufel, Mark Stettner, Christoph Kleinschnitz: Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. In: Neurology and Therapy. Band 11, Nr. 4, Dezember 2022, ISSN 2193-6536, S. 1637–1657, doi:10.1007/s40120-022-00395-z, PMID 36028604, PMC 9417089 (freier Volltext).
  • Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. In: Therapeutic Advances in Neurological Disorders. Band 17, Januar 2024, ISSN 1756-2864, doi:10.1177/17562864241229567, PMID 38348267, PMC 10860378 (freier Volltext).
  • Mark Vink, Tilman Grande, Matthias Kohl: Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic. In: Neurology and Therapy. Band 12, Nr. 1, Februar 2023, ISSN 2193-6536, S. 329–332, doi:10.1007/s40120-022-00426-9, PMID 36508159, PMC 9744047 (freier Volltext).
  • Matthias Kohl: Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. In: Therapeutic Advances in Neurological Disorders. Band 17, Januar 2024, ISSN 1756-2864, doi:10.1177/17562864241254268, PMID 38827241, PMC 11143864 (freier Volltext).

pubmed.ncbi.nlm.nih.gov

redirecter.toolforge.org

rtl.de

thelancet.com

  • Jonathan P. Piccini, Valeria Caso, u. a.: Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. In: The Lancet. Band 399, Nr. 10333, 9. April 2022, ISSN 0140-6736, S. 1383–1390, doi:10.1016/S0140-6736(22)00456-1, PMID 35385695 (thelancet.com [abgerufen am 6. April 2023]).

web.archive.org

zdb-katalog.de

  • Marta Rodríguez-Palmero, Angels Franch, Margarida Castell, Carme Pelegrí, Francisco J. Pérez-Cano, Christoph Kleinschnitz, Guido Stoll, Thomas Hünig, Cristina Castellote: Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody. In: The Journal of Rheumatology. Band 33, Nr. 1, Januar 2006, ISSN 1499-2752, S. 110–118, PMID 16395758 (jrheum.org).
  • Bernhard Nieswandt, Christoph Kleinschnitz, Guido Stoll: Ischaemic stroke: a thrombo-inflammatory disease? In: The Journal of Physiology. Band 589, Nr. 17, 1. September 2011, ISSN 1469-7793, S. 4115–4123, doi:10.1113/jphysiol.2011.212886, PMID 21768262, PMC 3180572 (freier Volltext).
  • Simon F. De Meyer, Friederike Langhauser, Steffen Haupeltshofer, Christoph Kleinschnitz, Ana I. Casas: Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives. In: Stroke. Band 53, Nr. 5, Mai 2022, ISSN 1524-4628, S. 1487–1499, doi:10.1161/STROKEAHA.122.038733, PMID 35360931.
  • Ina Hagedorn, Stefan Schmidbauer, u. a.: Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding. In: Circulation. Band 121, Nr. 13, 6. April 2010, ISSN 1524-4539, S. 1510–1517, doi:10.1161/CIRCULATIONAHA.109.924761, PMID 20308613.
  • Christoph Kleinschnitz, Guido Stoll, u. a.: Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. In: The Journal of Experimental Medicine. Band 203, Nr. 3, 20. März 2006, ISSN 0022-1007, S. 513–518, doi:10.1084/jem.20052458, PMID 16533887, PMC 2118228 (freier Volltext).
  • Thomas Renné, Miroslava Pozgajová, u. a.: Defective thrombus formation in mice lacking coagulation factor XII. In: The Journal of Experimental Medicine. Band 202, Nr. 2, 18. Juli 2005, ISSN 0022-1007, S. 271–281, doi:10.1084/jem.20050664, PMID 16009717, PMC 2213000 (freier Volltext).
  • Christoph Kleinschnitz, Nicholas Schwab, Peter Kraft, Ina Hagedorn, Angela Dreykluft, Tobias Schwarz, Madeleine Austinat, Bernhard Nieswandt, Heinz Wiendl, Guido Stoll: Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. In: Blood. Band 115, Nr. 18, 6. Mai 2010, ISSN 1528-0020, S. 3835–3842, doi:10.1182/blood-2009-10-249078, PMID 20215643.
  • Christoph Kleinschnitz, Peter Kraft, u. a.: Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. In: Blood. Band 121, Nr. 4, 24. Januar 2013, ISSN 1528-0020, S. 679–691, doi:10.1182/blood-2012-04-426734, PMID 23160472, PMC 3790947 (freier Volltext).
  • Michael K. Schuhmann, Peter Kraft, u. a.: CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke. In: Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism. Band 35, Nr. 1, Januar 2015, ISSN 1559-7016, S. 6–10, doi:10.1038/jcbfm.2014.175, PMID 25315859, PMC 4294400 (freier Volltext).
  • Jonathan P. Piccini, Valeria Caso, u. a.: Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. In: The Lancet. Band 399, Nr. 10333, 9. April 2022, ISSN 0140-6736, S. 1383–1390, doi:10.1016/S0140-6736(22)00456-1, PMID 35385695 (thelancet.com [abgerufen am 6. April 2023]).
  • Michael Fleischer, Martin Köhrmann, Sebastian Dolff, Fabian Szepanowski, Karsten Schmidt, Frank Herbstreit, Cansu Güngör, Benjamin Stolte, Katharina Marie Steiner, Christine Stadtler, Joachim Riße, Melanie Fiedler, Gerd Meyer Zu Hörste, Anne-K. Mausberg, Clemens Kill, Michael Forsting, Ulrich Sure, Ulf Dittmer, Oliver Witzke, Thorsten Brenner, Christoph Kleinschnitz, Mark Stettner: Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection. In: Therapeutic Advances in Neurological Disorders. Band 14, 2021, ISSN 1756-2856, S. 1756286421993701, doi:10.1177/1756286421993701, PMID 33737955, PMC 7934032 (freier Volltext).
  • Michael Heming, Xiaolin Li, Saskia Räuber, Anne K. Mausberg, Anna-Lena Börsch, Maike Hartlehnert, Arpita Singhal, I.-Na Lu, Michael Fleischer, Fabian Szepanowski, Oliver Witzke, Thorsten Brenner, Ulf Dittmer, Nir Yosef, Christoph Kleinschnitz, Heinz Wiendl, Mark Stettner, Gerd Meyer Zu Hörste: Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid. In: Immunity. Band 54, Nr. 1, 12. Januar 2021, ISSN 1097-4180, S. 164–175.e6, doi:10.1016/j.immuni.2020.12.011, PMID 33382973, PMC 7831653 (freier Volltext).
  • Michael Fleischer, Fabian Szepanowski, Muriel Tovar, Klaas Herchert, Hannah Dinse, Adam Schweda, Anne K. Mausberg, Dagny Holle-Lee, Martin Köhrmann, Julia Stögbauer, Daniel Jokisch, Martha Jokisch, Cornelius Deuschl, Eva-Maria Skoda, Martin Teufel, Mark Stettner, Christoph Kleinschnitz: Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients. In: Neurology and Therapy. Band 11, Nr. 4, Dezember 2022, ISSN 2193-6536, S. 1637–1657, doi:10.1007/s40120-022-00395-z, PMID 36028604, PMC 9417089 (freier Volltext).
  • Michael Fleischer, Fabian Szepanowski, Anne K Mausberg, Livia Asan, Ellen Uslar, Denise Zwanziger, Lothar Volbracht, Mark Stettner, Christoph Kleinschnitz: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. In: Therapeutic Advances in Neurological Disorders. Band 17, Januar 2024, ISSN 1756-2864, doi:10.1177/17562864241229567, PMID 38348267, PMC 10860378 (freier Volltext).
  • Mark Vink, Tilman Grande, Matthias Kohl: Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic. In: Neurology and Therapy. Band 12, Nr. 1, Februar 2023, ISSN 2193-6536, S. 329–332, doi:10.1007/s40120-022-00426-9, PMID 36508159, PMC 9744047 (freier Volltext).
  • Matthias Kohl: Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute sequelae of COVID-19. In: Therapeutic Advances in Neurological Disorders. Band 17, Januar 2024, ISSN 1756-2864, doi:10.1177/17562864241254268, PMID 38827241, PMC 11143864 (freier Volltext).
  • Ziyad Al-Aly, Hannah Davis, Lisa McCorkell, Letícia Soares, Sarah Wulf-Hanson, Akiko Iwasaki, Eric J. Topol: Long COVID science, research and policy. In: Nature Medicine. 9. August 2024, ISSN 1078-8956, S. 5, doi:10.1038/s41591-024-03173-6 (freier Volltext).
  • Todd E. Davenport, Svetlana Blitshteyn, Nicola Clague-Baker, David Davies-Payne, Glenn J. Treisman, Sarah F. Tyson: Long COVID Is Not a Functional Neurologic Disorder. In: Journal of Personalized Medicine. Band 14, Nr. 8, 29. Juli 2024, ISSN 2075-4426, doi:10.3390/jpm14080799 (freier Volltext).